The Scientific Committee

Pr. Jean-Marc Orgogozo
President

Jean-Marc Orgogozo, MD, was Professor of Neurology (1982) at the University of Bordeaux 2, he Chaired the Department of Clinical Neurosciences at the University Hospital of Bordeaux from 2006 to 2013. He is also qualified in Nuclear Medicine, Neurophysiology and Psychiatry. He is noted for his work in stroke, ageing and dementia.
He joined the Inserm unit of Neuro-epidemiology of Brain Aging and Dementia, now CRI 893, in 1993. He was also the Director of the ‘Bordeaux Neurocampus’ Federation of Basic and Clinical Neurosciences from 2011 to 2016.
Professor Orgogozo was Deputy Minister of the Regional Government of Aquitaine for universities, research and innovation from 2004 to 2010. He remained in charge of the allocation of research grants, in all domains of science, for the Regional Government until 2015.
Since 2016, he is a member of the Board of Directors and the Scientific Council of the HyperCube Institute.

François Chrion
Membrer of the Scientific Committee

He is Founding Co-Director of UVW, a renewable energy developer and mobile payment solution for energy platforms in East Africa.
He graduated from Ecole Polytechnique, Supélec as well as Georgia Institut of Technology, Atlanta where he graduated with a Masters in Biomedical.
After more than 20 years as an ICT consultant, François has been engaged in projects in Africa where Energy and ICT converge. His knowledge coupled with his Telecom and Banking industry experience has enabled him to participate in emerging technologies in Africa around Renewable Energy & Mobile Money Payment solutions.
He is also an early investor and advisor in Wandercraft, a French startup building an exoskeleton for disabled.
Since 2017, he is a member of the Scientific Committee of Institut HyperCube

Jean Paul Latgé
Member of the Scientific Committee

Systemic fungal infections are an increasingly significant medical problem in industrialised and developing countries and recognized as orphan diseases.
However, humans contract fungal diseases that cause severe damage or kill at least as many people as tuberculosis or malaria.
Though fungi infect billions of people every year, their contribution to the global burden is largely underestimated and unrecognized due to the lack of accurate and speedy diagnostic tests for these infections, but also because current systemic antifungal therapies are not always effective and the physiopathology of the disease remains poorly understood.
The purpose of my research is to better understand the biology of the human opportunistic fungal pathogens through genetic, biochemical and immunological approaches to better apprehend the fungal development in the immunocompetent and immunocompromised host.